Drug intelligence / Profile preview

dextromethorphan + diphenhydramine + levomenthol

Development stage
Unknown
Lead developer
Navana Pharmaceuticals
Modality
Small Molecules
Administration
Oral
01

Overview

Pires D is a fixed-dose combination over-the-counter (OTC) cough and cold preparation developed and marketed by Navana Pharmaceuticals. It contains dextromethorphan (a centrally-acting cough suppressant), diphenhydramine (a first-generation antihistamine with antitussive and anticholinergic properties), and levomenthol (a cooling agent that soothes throat irritation). Together, these components work synergistically to provide relief from persistent, dry, irritating coughs and associated upper respiratory symptoms, while also aiding restful sleep.

Brand names
Pires DPires-D
Other names
dextromethorphan + diphenhydramine + levomentholdextromethorphan + levomenthol + diphenhydraminediphenhydramine + dextromethorphan + levomenthol
02

Targets

HRH1 (Histamine H1 Receptor)mAChR (Muscarinic acetylcholine receptors)SIGMAR1 (Sigma non-opioid intracellular receptor 1)TRPM8 (Transient receptor potential cation channel subfamily M member 8)NMDAR (Glutamate receptor ionotropic, NMDA)

Beyond the preview

Go deeper on dextromethorphan + diphenhydramine + levomenthol.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on dextromethorphan + diphenhydramine + levomenthol.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call